or Try an Advanced Search...

    Technical Analysis for CNSP - CNS Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 0.13 4.53% 0.01
    CNSP closed down 2.52 percent on Wednesday, November 20, 2024, on 46 percent of normal volume. It ran into resistance at its 50 day moving average.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Flat Up
    Historical CNSP trend table...
    Date Alert Name Type % Chg
    50 DMA Resistance Bearish 4.53%
    20 DMA Support Bullish 4.53%
    Doji - Bearish? Reversal 4.53%
    Outside Day Range Expansion 4.53%
    Wide Bands Range Expansion 4.53%
    50 DMA Resistance Bearish 1.89%
    Crossed Above 20 DMA Bullish 1.89%
    Pocket Pivot Bullish Swing Setup 1.89%
    Wide Bands Range Expansion 1.89%
    Wide Bands Range Expansion 7.67%
    Older End-of-Day Signals for CNSP ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Resistance 20 minutes ago
    Rose Above Previous Day's High about 3 hours ago
    Rose Above Upper Bollinger Band about 3 hours ago
    Rose Above 50 DMA about 3 hours ago
    2x Volume Pace about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CNSP Chart by TradingView
    Basic chart:

    Profile

    CNS Pharmaceuticals, Inc., a preclinical stage pharmaceutical company, focuses on the development of anti-cancer drug candidates for the treatment of primary and metastatic brain, and central nervous system tumors. Its lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma. The company was founded in 2017 and is based in Houston, Texas.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Cancer Oncology Blastoma Glioblastoma Stage Pharmaceutical Brain Tumor Evofosfamide Central Nervous System Tumors

    Is CNSP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
    Nov 15 CNS Pharmaceuticals reports Q3 results
    Nov 15 CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
    Nov 4 CNS Pharmaceuticals Announces Virtual Investor KOL Connect Segment
    Nov 1 CNS Pharmaceuticals Granted Exception by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
    Oct 23 CNS Pharmaceuticals Announces Pricing of $3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
    Oct 23 Why Stride Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket
    Oct 10 CNS Pharmaceuticals Participates in Virtual Investor KOL Connect Segment
    Oct 8 CNS Pharmaceuticals to Participate in the 2024 Healthcare Virtual Summit Presented by Maxim Group LLC
    Sep 23 CNS Pharmaceuticals to Present at the 24th Annual Biotech in Europe Forum
    See more CNSP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 121.0
    52 Week Low 0.0955
    Average Volume 17,344,212
    200-Day Moving Average 5.98
    50-Day Moving Average 0.13
    20-Day Moving Average 0.12
    10-Day Moving Average 0.12
    Average True Range 0.02
    RSI (14) 47.92
    ADX 39.55
    +DI 34.65
    -DI 15.28
    Chandelier Exit (Long, 3 ATRs) 0.30
    Chandelier Exit (Short, 3 ATRs) 0.17
    Upper Bollinger Bands 0.14
    Lower Bollinger Band 0.10
    Percent B (%b) 0.54
    BandWidth 37.57
    MACD Line -0.01
    MACD Signal Line -0.01
    MACD Histogram 0.0028
    Fundamentals Value
    Market Cap 1.04 Million
    Num Shares 8.43 Million
    EPS -7.60
    Price-to-Earnings (P/E) Ratio -0.02
    Price-to-Sales 0.00
    Price-to-Book 4.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.16
    Resistance 3 (R3) 0.16 0.15 0.16
    Resistance 2 (R2) 0.15 0.14 0.15 0.16
    Resistance 1 (R1) 0.14 0.13 0.14 0.14 0.15
    Pivot Point 0.12 0.12 0.13 0.12 0.12
    Support 1 (S1) 0.11 0.11 0.12 0.11 0.09
    Support 2 (S2) 0.10 0.11 0.10 0.09
    Support 3 (S3) 0.08 0.10 0.09
    Support 4 (S4) 0.08